Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Cetuximab can cause unusual hair growth and hair loss.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Vorasidenib can cause unusual hair growth.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Ritlecitinib can help about 14,000 people with severe hair loss.